Relationship between residual plasma viremia and the size of HIV proviral DNA reservoirs in infected individuals receiving effective antiretroviral therapy.

@article{Chun2011RelationshipBR,
  title={Relationship between residual plasma viremia and the size of HIV proviral DNA reservoirs in infected individuals receiving effective antiretroviral therapy.},
  author={T. Chun and D. Murray and J. Justement and C. Hallahan and S. Moir and C. Kovacs and A. Fauci},
  journal={The Journal of infectious diseases},
  year={2011},
  volume={204 1},
  pages={
          135-8
        }
}
Residual plasma viremia (<50 copies/mL) persists in certain human immunodeficiency virus (HIV)-infected individuals receiving antiretroviral therapy (ART); however, the relationship between the degree of residual plasma viremia, the size of HIV reservoirs, and the level of immune activation has not been delineated. Here, we demonstrate that residual plasma viremia correlates with the size of the CD4(+) T cell viral reservoir, but not with markers of immune activation, suggesting that… Expand
Dynamics of HIV DNA and residual viremia in patients treated with a raltegravir-containing regimen.
Residual Viremia in Treated HIV+ Individuals
Lack of correlation between the size of HIV proviral DNA reservoir and the level of immune activation in HIV-infected patients with a sustained undetectable HIV viral load for 10 years.
Tracking replication-competent HIV reservoirs in infected individuals
  • T. Chun
  • Medicine
  • Current opinion in HIV and AIDS
  • 2013
Evaluation of HIV-DNA and inflammatory markers in HIV-infected individuals with different viral load patterns
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 16 REFERENCES
Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy.
Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy.
  • T. Chun, L. Stuyver, +6 authors A. Fauci
  • Biology, Medicine
  • Proceedings of the National Academy of Sciences of the United States of America
  • 1997
Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy
...
1
2
...